Evidence map›Paper›PMID 35493922›Full record

ReviewFrontiers in aging neuroscience2022

Novel Non-invasive Transcranial Electrical Stimulation for Parkinson's Disease.

Rui Ni, Ye Yuan, Li Yang, Qiujian Meng, Ying Zhu, Yiya Zhong, Zhenqian Cao, Shengzhao Zhang, Wenjun Yao, Daping Lv and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Rui NiDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Ye YuanDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Li YangDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Qiujian MengDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Ying ZhuDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Yiya ZhongDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Zhenqian CaoDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Shengzhao ZhangDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Wenjun YaoDepartment of Radiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Daping LvDepartment of Neurology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.
Xin ChenDepartment of Neurology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.
Xianwen ChenDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Junjie BuDepartment of Intelligent Medical Engineering, School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Anhui Medical University · CNFourth Affiliated Hospital of Anhui Medical University · CNImperial College London · GBSecond Hospital of Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional transcranial electrical stimulation (tES) is a non-invasive method to modulate brain activity and has been extensively used in the treatment of Parkinson's disease (PD). Despite promising prospects, the efficacy of conventional tES in PD treatment is highly variable across different studies. Therefore, many have tried to optimize tES for an improved therapeutic efficacy by developing novel tES intervention strategies. Until now, these novel clinical interventions have not been discussed or reviewed in the context of PD therapy. In this review, we focused on the efficacy of these novel strategies in PD mitigation, classified them into three categories based on their distinct technical approach to circumvent conventional tES problems. The first category has novel stimulation modes to target different modulating mechanisms, expanding the rang of stimulation choices hence enabling the ability to modulate complex brain circuit or functional networks. The second category applies tES as a supplementary intervention for PD hence amplifies neurological or behavioral improvements. Lastly, the closed loop tES stimulation can provide self-adaptive individualized stimulation, which enables a more specialized intervention. In summary, these novel tES have validated potential in both alleviating PD symptoms and improving understanding of the pathophysiological mechanisms of PD. However, to assure wide clinical used of tES therapy for PD patients, further large-scale trials are required.

Indexed as

closed loop stimulationneuromodulationnon-invasive treatmentParkinson’s diseasetranscranial electrical stimulation (tES)

Identifiers

PMID35493922
PMCPMC9039727
OpenAlexW4223426462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.